Identification of driver genes based on gene mutational effects and network centrality
暂无分享,去创建一个
Jianping Zhao | Pi-Jing Wei | Chun-Hou Zheng | Yun-Yun Tang | Junfeng Xia | Rui-Fen Cao | C. Zheng | Pi-Jing Wei | Junfeng Xia | Yun-Yun Tang | Jian-ping Zhao | Ruifen Cao
[1] Xing-Ming Zhao,et al. Identifying cancer-related microRNAs based on gene expression data , 2015, Bioinform..
[2] K. Aihara,et al. Personalized characterization of diseases using sample-specific networks , 2016, bioRxiv.
[3] David Haussler,et al. PARADIGM-SHIFT predicts the function of mutations in multiple cancers using pathway impact analysis , 2012, Bioinform..
[4] Sandhya Rani,et al. Human Protein Reference Database—2009 update , 2008, Nucleic Acids Res..
[5] J. P. Hou,et al. DawnRank: discovering personalized driver genes in cancer , 2014, Genome Medicine.
[6] Kern Rei Chng,et al. Patient-specific driver gene prediction and risk assessment through integrated network analysis of cancer omics profiles , 2015, Nucleic acids research.
[7] Joshua M. Stuart,et al. The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.
[8] A. Bashashati,et al. DriverNet: uncovering the impact of somatic driver mutations on transcriptional networks in cancer , 2012, Genome Biology.
[9] H. Carter,et al. Identifying Mendelian disease genes with the Variant Effect Scoring Tool , 2013, BMC Genomics.
[10] R. Shamir,et al. PRODIGY: personalized prioritization of driver genes , 2018, bioRxiv.
[11] M. Guyer,et al. Charting a course for genomic medicine from base pairs to bedside , 2011, Nature.
[12] J. Soulier,et al. Copy-number analysis identified new prognostic marker in acute myeloid leukemia , 2017, Leukemia.
[13] C. Sander,et al. Mutual exclusivity analysis identifies oncogenic network modules. , 2012, Genome research.
[14] Tom R. Gaunt,et al. Predicting the functional consequences of cancer-associated amino acid substitutions , 2013, Bioinform..
[15] Dennis C. Friedrich,et al. Whole-exome sequencing and clinical interpretation of formalin-fixed , paraffin-embedded tumor samples to guide precision cancer medicine , 2014 .
[16] Kyusam Choi,et al. The expression of phospho-AKT1 and phospho-MTOR is associated with a favorable prognosis independent of PTEN expression in intrahepatic cholangiocarcinomas , 2012, Modern Pathology.
[17] Hyunju Lee,et al. DEOD: uncovering dominant effects of cancer-driver genes based on a partial covariance selection method , 2015, Bioinform..
[18] Matthew B. Callaway,et al. MuSiC: Identifying mutational significance in cancer genomes , 2012, Genome research.
[19] M. Frame,et al. Src in cancer: deregulation and consequences for cell behaviour. , 2002, Biochimica et biophysica acta.
[20] A. Sivachenko,et al. Sequence analysis of mutations and translocations across breast cancer subtypes , 2012, Nature.
[21] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[22] M. Stratton,et al. The cancer genome , 2009, Nature.
[23] Thomas Sauerwald,et al. HIT'nDRIVE: patient-specific multidriver gene prioritization for precision oncology , 2017, Genome research.
[24] A. Sparks,et al. The Genomic Landscapes of Human Breast and Colorectal Cancers , 2007, Science.
[25] R. Salgia,et al. Fyn , 2010, Cancer.
[26] Hannah Carter,et al. CHASM and SNVBox: toolkit for detecting biologically important single nucleotide mutations in cancer , 2011, Bioinform..
[27] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[28] Guojun Li,et al. MaxMIF: A New Method for Identifying Cancer Driver Genes through Effective Data Integration , 2018, Advanced science.
[29] S. Gabriel,et al. Discovery and saturation analysis of cancer genes across 21 tumor types , 2014, Nature.
[30] M. Stratton. Journeys into the genome of cancer cells , 2013, EMBO molecular medicine.
[31] Shi-Hua Zhang,et al. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data , 2013, BMC Systems Biology.
[32] Emidio Capriotti,et al. Bioinformatics for personal genome interpretation , 2012, Briefings Bioinform..
[33] Tom R. Gaunt,et al. Predicting the Functional, Molecular, and Phenotypic Consequences of Amino Acid Substitutions using Hidden Markov Models , 2012, Human mutation.
[34] Huanbin Wang,et al. Somatic gene copy number alterations in colorectal cancer: new quest for cancer drivers and biomarkers , 2016, Oncogene.
[35] C. Onodera,et al. Genomic Analysis of Pigmented Epithelioid Melanocytomas Reveals Recurrent Alterations in PRKAR1A, and PRKCA Genes , 2017, The American journal of surgical pathology.
[36] Jie Xu,et al. Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy , 2016, Oncogene.
[37] Kenny Q. Ye,et al. An integrated map of genetic variation from 1,092 human genomes , 2012, Nature.
[38] R. Salgia,et al. Fyn: a novel molecular target in cancer. , 2010, Cancer.
[39] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[40] Luonan Chen,et al. Biomolecular Networks: Methods and Applications in Systems Biology , 2009 .
[41] K. Kinzler,et al. Cancer Genome Landscapes , 2013, Science.
[42] P. Bork,et al. GEAR: A database of Genomic Elements Associated with drug Resistance , 2017, Scientific Reports.
[43] Peilin Jia,et al. VarWalker: Personalized Mutation Network Analysis of Putative Cancer Genes from Next-Generation Sequencing Data , 2014, PLoS Comput. Biol..
[44] X. Hua,et al. DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies , 2019, Nucleic acids research.
[45] Xing-Ming Zhao,et al. Integrative analysis of mutational and transcriptional profiles reveals driver mutations of metastatic breast cancers , 2016, Cell Discovery.
[46] S. Brunak,et al. Network biology concepts in complex disease comorbidities , 2016, Nature Reviews Genetics.
[47] E. Birney,et al. Patterns of somatic mutation in human cancer genomes , 2007, Nature.
[48] Xing-Ming Zhao,et al. Identifying Disease Associated miRNAs Based on Protein Domains , 2016, IEEE/ACM Transactions on Computational Biology and Bioinformatics.
[49] Yicheng Zhang,et al. Identifying influential nodes in complex networks , 2012 .
[50] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[51] Brian H. Dunford-Shore,et al. Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.
[52] Lei Zhang,et al. Discovering personalized driver mutation profiles of single samples in cancer by network control strategy , 2018, Bioinform..
[53] David Tamborero,et al. OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes , 2013, Bioinform..
[54] Leyla Isik,et al. Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. , 2009, Cancer research.
[55] G. Mills,et al. CanDrA: Cancer-Specific Driver Missense Mutation Annotation with Optimized Features , 2013, PloS one.
[56] Chuang Liu,et al. A Gene Gravity Model for the Evolution of Cancer Genomes: A Study of 3,000 Cancer Genomes across 9 Cancer Types , 2015, PLoS Comput. Biol..
[57] Xing-Ming Zhao,et al. CSTEA: a webserver for the Cell State Transition Expression Atlas , 2017, Nucleic Acids Res..
[58] Adam Kiezun,et al. Whole-exome sequencing and clinical interpretation of FFPE tumor samples to guide precision cancer medicine , 2013, Nature Medicine.
[59] Junfeng Xia,et al. LNDriver: identifying driver genes by integrating mutation and expression data based on gene-gene interaction network , 2016, BMC Bioinformatics.
[60] R. Bernards,et al. Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR , 2012, Nature.
[61] Hannah Carter,et al. CRAVAT: cancer-related analysis of variants toolkit , 2013, Bioinform..
[62] Benjamin J. Raphael,et al. Pan-Cancer Network Analysis Identifies Combinations of Rare Somatic Mutations across Pathways and Protein Complexes , 2014, Nature Genetics.
[63] Joshua F. McMichael,et al. DGIdb - Mining the druggable genome , 2013, Nature Methods.
[64] Tao Zeng,et al. A novel network control model for identifying personalized driver genes in cancer , 2019, PLoS Comput. Biol..
[65] F. Supek,et al. MUFFINN: cancer gene discovery via network analysis of somatic mutation data , 2016, Genome Biology.
[66] klaguia. International Network of Cancer Genome Projects , 2010 .